Arena Pharmaceuticals Inc
ARNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$104.09
4.1% upside
Current Fair Value
4.1% upsideUndervalued by 4.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-509,258,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-11.33 |
| Beta | 0.55 |
| Outstanding Shares | 61,378,000 |
Return
| Return on Equity | -91.56% |
|---|---|
| Return on Assets | -78.56% |
| Return on Invested Capital | -76.87% |
Valuation & Multiples
| P/E Ratio | -8.83 |
|---|---|
| PEG | -32.23 |
| Price to Sales | - |
| Price to Book Ratio | 10.0 |
| Enterprise Value to Revenue | -9430.7 |
| Enterprise Value to EBIT | 0.92 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Arena Pharmaceuticals Inc
CEO: Amit Munshi